Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04889898 · ClinicalTrials.gov registry record
Remote Speech and Swallowing Assessment in ALS
A clinical trial of Amyotrophic Lateral Sclerosis, sponsored by Milton S. Hershey Medical Center.
- Active
- Registry status
- 170
- Enrollment target
- 1
- Study location
NCT04889898: Active study of Amyotrophic Lateral Sclerosis, sponsored by Milton S. Hershey Medical Center.
NCT04889898 is a study of Amyotrophic Lateral Sclerosis that is active but no longer recruiting, run by Milton S. Hershey Medical Center. The registered enrollment target is 170 participants, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04889898, a study of Amyotrophic Lateral Sclerosis, is active but no longer recruiting, sponsored by Milton S. Hershey Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose a longitudinal home study of ALS patients to measure the severity of speech and swallowing (bulbar) impairment via a smartphone-based, remote speech and swallow assessment (rSSA). The study is designed to assess the feasibility and validity of such a monitoring intervention. Furthermore, it is proposed that regular monitoring of these two bulbar processes may shed light on their co-evolution over the course of ALS.
Primary Outcome
Audio recordings of speech tasks and spontaneous swallowing task
Conditions Studied
Interventions
- DEVICE Digital recording of speech and swallow sounds using the Beiwe Digital Health App on a personal smartphone
- RADIATION Modified Barium Swallow Study (MBSS)
- BEHAVIORAL Speech Intelligibility Test (SIT)
- BEHAVIORAL SIT Scoring
Study Locations (1)
Pennsylvania
- Hershey Medical Center ALS Clinic - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2026-09 |
What the registry record for NCT04889898 still lists
NCT04889898 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 4 interventions - of which Digital recording of speech and swallow sounds using the Beiwe Digital Health App on a personal smartphone is the first listed.
NCT04889898 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04889898 about?
NCT04889898 is a clinical study titled "Remote Speech and Swallowing Assessment in ALS". The investigators propose a longitudinal home study of ALS patients to measure the severity of speech and swallowing (bulbar) impairment via a smartphone-based, remote speech and swallow assessment (rSSA). The study is designed to assess the feasibility and validity of such a monitoring intervention...
What is the current status of trial NCT04889898?
This trial is currently active not recruiting. The enrollment target is 170 participants. The study started on 2022-01-01. Estimated completion is 2026-09.
What conditions does trial NCT04889898 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.
What interventions are being tested in trial NCT04889898?
The interventions under investigation include: Digital recording of speech and swallow sounds using the Beiwe Digital Health App on a personal smartphone (DEVICE), Modified Barium Swallow Study (MBSS) (RADIATION), Speech Intelligibility Test (SIT) (BEHAVIORAL), SIT Scoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT04889898?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04889898 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04889898's enrollment target sits among peer trials
170 32nd of 102 higher than 71 of 102 other Amyotrophic Lateral Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
PREVENT ALL ALS Study
RECRUITING
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI